Results 131 to 140 of about 212,546 (262)
Leukemia Cutis in Acute Myeloid Leukemia: A Case Report. [PDF]
Saied ASS +4 more
europepmc +1 more source
Abstract Systemic mastocytosis (SM) is a clonal mast cell (MC) disorder characterized by aberrant immunophenotypes, including expression of CD25, CD2, and occasionally CD30. CD123, the α‐subunit of the interleukin‐3 receptor, is a therapeutic target in hematologic malignancies and has been reported to be expressed on neoplastic MCs by ...
Ryan C. Shean +2 more
wiley +1 more source
Abstract Accurate quantification of chimeric antigen receptor (CAR) T cells is essential for monitoring post‐infusion CART expansion and persistence and for real‐time clinical decision‐making. Multiparameter flow cytometry (MFC) enables rapid, live‐cell detection with absolute quantification and concurrent immunophenotypic characterization. This review
Jianhua Ling, Wei Wang, Sa A. Wang
wiley +1 more source
Brain Abscess Following CPX-351 Treatment in a Patient With Acute Myeloid Leukemia. [PDF]
Yamaga Y +4 more
europepmc +1 more source
Circulating monocyte partitioning and its alteration in hematological chronic neoplasms
Abstract Circulating monocyte partitioning refers to the relative quantification of the three main monocyte subsets in the peripheral blood, namely classical (cMo), intermediate (iMo), and non‐classical (ncMo) monocytes, as assessed by flow cytometry, a new nomenclature described 15 years ago.
Sihem Tarfi +4 more
wiley +1 more source
Abstract Flow cytometry is an essential component of routine hematological lab testing. Many computational methods have been proposed for the analysis of flow cytometry data, but most have focused on supervised learning for just one or a few specific disorders.
Brendan O'Fallon +4 more
wiley +1 more source
Roles of extracellular vesicles in the pathogenesis of chronic myeloid leukemia. [PDF]
Hrdinova T, Kupcova Skalnikova H.
europepmc +1 more source
Maintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions. [PDF]
Velarde P, Aloufi A, Sanford D.
europepmc +1 more source

